News

Published on 7 Oct 2023 on Simply Wall St. via Yahoo Finance

An excellent week for Bicycle Therapeutics plc's (NASDAQ:BCYC) institutional owners who own 64% as...


Article preview image

Key Insights

Given the large stake in the stock by institutions, Bicycle Therapeutics' stock price might be vulnerable to their trading decisionsThe top 14 shareholders own 51% of the companyOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock

Every investor in Bicycle Therapeutics plc (NASDAQ:BCYC) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 64% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

NASDAQ.BCYC price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug...

On Thursday, Bicycle Therapeutics plc (NASDAQ:BCYC) announced that it presented data showing the...

Benzinga · via Yahoo Finance 13 Dec 2024

Is Bicycle Therapeutics plc (BCYC) Top Performing European Stock Heading into...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this...

Insider Monkey · via Yahoo Finance 13 Nov 2024

Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks · via Yahoo Finance 26 May 2024

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Bicycle Therapeutics BCYC shares rallied 9.6% in the last trading session on May 23 after the com...

Zacks via Yahoo Finance 24 May 2024

Is Bicycle Therapeutics (BCYC) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 21 May 2024

Upgrade: Analysts Just Made A Massive Increase To Their Bicycle Therapeutics plc (NASDAQ:BCYC)...

Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders will have a reason to smile today, with the a...

Simply Wall St. via Yahoo Finance 7 May 2024

Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade

Bicycle Therapeutics PLC Sponsored ADR (BCYC) could be a solid addition to your portfolio given i...

Zacks via Yahoo Finance 7 May 2024

Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And...

It's been a good week for Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders, because the compan...

Simply Wall St. via Yahoo Finance 23 Feb 2024

Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares

On January 3, 2024, CEO Kevin Lee sold 8,703 shares of Bicycle Therapeutics PLC (NASDAQ:BCYC), ac...

GuruFocus.com via Yahoo Finance 5 Jan 2024

Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Just Trimmed Their Revenue Forecasts By 13%

One thing we could say about the analysts on Bicycle Therapeutics plc (NASDAQ:BCYC) - they aren't...

Simply Wall St. via Yahoo Finance 7 Nov 2023